Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HCP1004 in Chronic Low-Back Pain Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of HCP1004 in chronic low back pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• HCP1004

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Chronic Low-back Pain | Phase 3 | Status: COMPLETED